vs

Side-by-side financial comparison of Alpha Metallurgical Resources, Inc. (AMR) and CLOVER HEALTH INVESTMENTS, CORP. (CLOV). Click either name above to swap in a different company.

Alpha Metallurgical Resources, Inc. is the larger business by last-quarter revenue ($519.1M vs $487.7M, roughly 1.1× CLOVER HEALTH INVESTMENTS, CORP.). Alpha Metallurgical Resources, Inc. runs the higher net margin — -3.3% vs -10.1%, a 6.8% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (44.7% vs -15.7%). Alpha Metallurgical Resources, Inc. produced more free cash flow last quarter ($-10.0M vs $-69.0M). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (18.6% CAGR vs -22.4%).

Alpha Metallurgical Resources, formerly Contura Energy, is a leading coal supplier with underground and surface coal mining complexes across Northern and Central Appalachia. Contura owns large coal basins in Pennsylvania, Virginia and West Virginia which supply both metallurgical coal to produce steel and thermal coal to generate power.

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

AMR vs CLOV — Head-to-Head

Bigger by revenue
AMR
AMR
1.1× larger
AMR
$519.1M
$487.7M
CLOV
Growing faster (revenue YoY)
CLOV
CLOV
+60.4% gap
CLOV
44.7%
-15.7%
AMR
Higher net margin
AMR
AMR
6.8% more per $
AMR
-3.3%
-10.1%
CLOV
More free cash flow
AMR
AMR
$59.0M more FCF
AMR
$-10.0M
$-69.0M
CLOV
Faster 2-yr revenue CAGR
CLOV
CLOV
Annualised
CLOV
18.6%
-22.4%
AMR

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
AMR
AMR
CLOV
CLOV
Revenue
$519.1M
$487.7M
Net Profit
$-17.3M
$-49.3M
Gross Margin
Operating Margin
-4.1%
-10.1%
Net Margin
-3.3%
-10.1%
Revenue YoY
-15.7%
44.7%
Net Profit YoY
-711.2%
-123.2%
EPS (diluted)
$-1.35

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AMR
AMR
CLOV
CLOV
Q4 25
$519.1M
$487.7M
Q3 25
$525.2M
$496.6M
Q2 25
$548.7M
$477.6M
Q1 25
$529.7M
$462.3M
Q4 24
$615.4M
$337.0M
Q3 24
$669.8M
$331.0M
Q2 24
$800.1M
$356.3M
Q1 24
$861.3M
$346.9M
Net Profit
AMR
AMR
CLOV
CLOV
Q4 25
$-17.3M
$-49.3M
Q3 25
$-5.5M
$-24.4M
Q2 25
$-5.0M
$-10.6M
Q1 25
$-33.9M
$-1.3M
Q4 24
$-2.1M
$-22.1M
Q3 24
$3.8M
$-9.2M
Q2 24
$58.9M
$7.4M
Q1 24
$127.0M
$-19.2M
Gross Margin
AMR
AMR
CLOV
CLOV
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
24.5%
Q2 24
30.3%
Q1 24
23.6%
Operating Margin
AMR
AMR
CLOV
CLOV
Q4 25
-4.1%
-10.1%
Q3 25
-0.5%
-4.9%
Q2 25
0.5%
-2.2%
Q1 25
-7.6%
-0.3%
Q4 24
1.6%
-6.4%
Q3 24
0.8%
-2.7%
Q2 24
8.8%
2.0%
Q1 24
16.5%
-6.5%
Net Margin
AMR
AMR
CLOV
CLOV
Q4 25
-3.3%
-10.1%
Q3 25
-1.1%
-4.9%
Q2 25
-0.9%
-2.2%
Q1 25
-6.4%
-0.3%
Q4 24
-0.3%
-6.6%
Q3 24
0.6%
-2.8%
Q2 24
7.4%
2.1%
Q1 24
14.7%
-5.5%
EPS (diluted)
AMR
AMR
CLOV
CLOV
Q4 25
$-1.35
Q3 25
$-0.42
Q2 25
$-0.38
Q1 25
$-2.60
Q4 24
$-0.09
Q3 24
$0.29
Q2 24
$4.49
Q1 24
$9.59

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AMR
AMR
CLOV
CLOV
Cash + ST InvestmentsLiquidity on hand
$415.6M
$78.3M
Total DebtLower is stronger
$9.8M
Stockholders' EquityBook value
$1.5B
$308.7M
Total Assets
$2.3B
$541.0M
Debt / EquityLower = less leverage
0.01×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AMR
AMR
CLOV
CLOV
Q4 25
$415.6M
$78.3M
Q3 25
$457.9M
Q2 25
$449.0M
Q1 25
$448.0M
Q4 24
$481.6M
$194.5M
Q3 24
$484.6M
$288.0M
Q2 24
$336.1M
$254.8M
Q1 24
$269.4M
$208.3M
Total Debt
AMR
AMR
CLOV
CLOV
Q4 25
$9.8M
Q3 25
$2.9M
Q2 25
$3.1M
Q1 25
$2.4M
Q4 24
$2.9M
Q3 24
$3.6M
Q2 24
$5.3M
Q1 24
$6.0M
Stockholders' Equity
AMR
AMR
CLOV
CLOV
Q4 25
$1.5B
$308.7M
Q3 25
$1.6B
$340.9M
Q2 25
$1.6B
$344.2M
Q1 25
$1.6B
$336.1M
Q4 24
$1.6B
$341.1M
Q3 24
$1.7B
$342.2M
Q2 24
$1.6B
$324.9M
Q1 24
$1.6B
$292.5M
Total Assets
AMR
AMR
CLOV
CLOV
Q4 25
$2.3B
$541.0M
Q3 25
$2.3B
$559.7M
Q2 25
$2.4B
$575.0M
Q1 25
$2.4B
$583.7M
Q4 24
$2.4B
$580.7M
Q3 24
$2.5B
$653.0M
Q2 24
$2.5B
$674.2M
Q1 24
$2.5B
$671.8M
Debt / Equity
AMR
AMR
CLOV
CLOV
Q4 25
0.01×
Q3 25
0.00×
Q2 25
0.00×
Q1 25
0.00×
Q4 24
0.00×
Q3 24
0.00×
Q2 24
0.00×
Q1 24
0.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AMR
AMR
CLOV
CLOV
Operating Cash FlowLast quarter
$19.0M
$-66.9M
Free Cash FlowOCF − Capex
$-10.0M
$-69.0M
FCF MarginFCF / Revenue
-1.9%
-14.1%
Capex IntensityCapex / Revenue
5.6%
0.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$17.8M
$-69.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AMR
AMR
CLOV
CLOV
Q4 25
$19.0M
$-66.9M
Q3 25
$50.5M
$12.1M
Q2 25
$53.2M
$5.4M
Q1 25
$22.2M
$-16.3M
Q4 24
$56.3M
$34.8M
Q3 24
$189.5M
$50.0M
Q2 24
$138.1M
$44.8M
Q1 24
$196.1M
$25.9M
Free Cash Flow
AMR
AMR
CLOV
CLOV
Q4 25
$-10.0M
$-69.0M
Q3 25
$25.4M
$11.4M
Q2 25
$18.6M
$4.8M
Q1 25
$-16.3M
$-16.5M
Q4 24
$13.6M
$33.3M
Q3 24
$158.0M
$49.6M
Q2 24
$77.0M
$44.4M
Q1 24
$132.5M
$25.5M
FCF Margin
AMR
AMR
CLOV
CLOV
Q4 25
-1.9%
-14.1%
Q3 25
4.8%
2.3%
Q2 25
3.4%
1.0%
Q1 25
-3.1%
-3.6%
Q4 24
2.2%
9.9%
Q3 24
23.6%
15.0%
Q2 24
9.6%
12.5%
Q1 24
15.4%
7.3%
Capex Intensity
AMR
AMR
CLOV
CLOV
Q4 25
5.6%
0.4%
Q3 25
4.8%
0.1%
Q2 25
6.3%
0.1%
Q1 25
7.3%
0.0%
Q4 24
6.9%
0.5%
Q3 24
4.7%
0.1%
Q2 24
7.6%
0.1%
Q1 24
7.4%
0.1%
Cash Conversion
AMR
AMR
CLOV
CLOV
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
49.81×
Q2 24
2.34×
6.04×
Q1 24
1.54×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons